InsidersTradesSigma
Follow the Baxalta Inc share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on US US, under the oversight of SEC (Form 4). The latest transaction was disclosed on 2 February 2016 (J). Among the most active insiders: BAXTER INTERNATIONAL INC. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Baxalta Inc is a biopharmaceutical company focused on developing treatments for hematologic and immunologic diseases. It was founded in 2015 and is listed on NASDAQ under the symbol BXLT.